Wasatch Advisors Inc Amgen Inc Transaction History

Wasatch Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $3.82 Million - $4.46 Million	-22,540 Closed	0 $0
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $2.11 Million - $2.36 Million	-12,508 Reduced 35.69%	22,540 $0
Q2 2017 Aug 16, 2017	BUY	N/A	35,048	35,048 $0

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.